290 studies found for:    Open Studies | "Hepatitis C"
Show Display Options
Rank Status Study
21 Recruiting Effect of Camel Milk on Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon,  Ribavirin, camel milk;   Drug: Peginterferon,  Ribavirin
22 Unknown  Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated interferon alfa and ribavirin
23 Unknown  Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance
Conditions: Chronic Hepatitis c;   Insulin Resistance
Interventions: Drug: metformin;   Drug: pegylated-IFN;   Drug: ribavirin
24 Unknown  Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin Treatments
Condition: Chronic Hepatitis C
Intervention:
25 Unknown  Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients?
Condition: Chronic Hepatitis C
Interventions: Drug: Peg + Vitamin D + Ribavirin;   Drug: Peg +  Ribavirin
26 Recruiting Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients
Condition: Chronic Hepatitis C Infection
Intervention:
27 Recruiting A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b- or Genotype 4-Infected Participants
Condition: Hepatitis C, Chronic
Interventions: Drug: Simeprevir;   Drug: Daclatasvir
28 Unknown  Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients
Condition: Chronic Hepatitis C
Intervention: Dietary Supplement: Vit D
29 Recruiting BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: BIP 48 (Peginterferon alfa 2b 48kDA);   Drug: Peginterferon alfa 2a 40kDA
30 Unknown  Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
Conditions: Chronic Hepatitis C;   Neoplasms
Intervention: Drug: pegylated interferon alpha 2a and plus ribavirin
31 Recruiting Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl Alone or in Combination With Ribavirin in Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Chlorcyclizine HCL plus Ribavirin;   Drug: Chlorcyclizine HCL Only
32 Unknown  Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Reiferon retard
33 Recruiting Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)
Condition: Chronic Hepatitis C Infection
Interventions: Drug: Valacyclovir;   Drug: Placebo
34 Unknown  PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)
Condition: Chronic Hepatitis C
Intervention: Drug: Peginterferon alfa-2a and Ribavirin
35 Recruiting Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated With Peginterferon Alpha-2a and Ribavirin
Condition: Chronic Hepatitis C
Intervention: Device: chronic hepatitis C
36 Recruiting An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease
Condition: Hepatitis C, Chronic
Interventions: Drug: Simeprevir;   Drug: Daclatasvir;   Drug: Sofosbuvir
37 Unknown  A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Celgosivir;   Drug: Peginterferon alfa 2b + ribavirin
38 Not yet recruiting Undiagnosed Hepatitis C Infection in an Urban Hospital
Condition: Hepatitis C
Intervention:
39 Recruiting Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus
Condition: Hepatitis C
Interventions: Drug: DCV/ASV/BMS-791325;   Drug: DCV/ASV/BMS-791325 + RBV
40 Recruiting The Pathogenesis of Hepatitis C Virus Vertical Transmission
Conditions: Hepatitis C;   Infection Transmission, Maternal-Fetal
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years